Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($) $ in Millions	Total	Common stock	Treasury stock	Additional paid-in capital	Retained earnings	Net parent investment	Accumulated other comprehensive income (loss) – net	Equity attributable to noncontrolling interests
Equity, beginning balance (in shares) at Dec. 31, 2022		0
Equity, beginning balance at Dec. 31, 2022	$ 9,362	$ 0		$ 0	$ 0	$ 11,235	$ (1,878)	$ 5
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net transfers from GE, including Spin-Off-related adjustments	(2,840)					(4,842)	2,000	2
Issuance of common stock in connection with the Spin-Off and reclassification of net parent investment (in shares)		454,000,000
Issuance of common stock in connection with the Spin-Off and reclassification of net parent investment	0	$ 5		6,388		(6,393)
Issuance of shares under equity awards, net of shares withheld for taxes and other (in shares)		1,000,000
Net income attributable to GE HealthCare	1,165				1,165
Dividends declared	(41)				(41)
Other comprehensive income (loss) attributable to GE HealthCare	(402)						(402)
Changes in equity attributable to noncontrolling interests	4							4
Share-based compensation	81			81
Changes in equity due to redemption value adjustments on redeemable noncontrolling interests	(187)				(187)
Equity, ending balance (in shares) at Sep. 30, 2023		455,000,000
Equity, ending balance at Sep. 30, 2023	7,142	$ 5		6,469	937	0	(280)	11
Equity, beginning balance (in shares) at Jun. 30, 2023		455,000,000
Equity, beginning balance at Jun. 30, 2023	7,114	$ 5		6,451	576	0	70	12
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of shares under equity awards, net of shares withheld for taxes and other	(11)			(11)
Net income attributable to GE HealthCare	375				375
Dividends declared	(14)				(14)
Other comprehensive income (loss) attributable to GE HealthCare	(350)						(350)
Changes in equity attributable to noncontrolling interests	(1)							(1)
Share-based compensation	29			29
Equity, ending balance (in shares) at Sep. 30, 2023		455,000,000
Equity, ending balance at Sep. 30, 2023	$ 7,142	$ 5		6,469	937	$ 0	(280)	11
Equity, beginning balance (in shares) at Dec. 31, 2023	455,342,290	455,000,000
Equity, beginning balance at Dec. 31, 2023	$ 7,145	$ 5	$ 0	6,493	1,326		(691)	12
Treasury stock, beginning balance (in shares) at Dec. 31, 2023	0		0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of shares under equity awards, net of shares withheld for taxes and other (in shares)		2,000,000
Issuance of shares under equity awards, net of shares withheld for taxes and other	$ (59)		$ (25)	(34)
Net income attributable to GE HealthCare	1,272				1,272
Dividends declared	(41)				(41)
Other comprehensive income (loss) attributable to GE HealthCare	(80)						(80)
Changes in equity attributable to noncontrolling interests	6							6
Share-based compensation	$ 92			92
Equity, ending balance (in shares) at Sep. 30, 2024	457,144,443	457,000,000
Equity, ending balance at Sep. 30, 2024	$ 8,335	$ 5	$ (25)	6,551	2,558		(771)	18
Treasury stock, ending balance (in shares) at Sep. 30, 2024	(291,053)		0
Equity, beginning balance (in shares) at Jun. 30, 2024		457,000,000
Equity, beginning balance at Jun. 30, 2024	$ 7,817	$ 5	$ 0	6,540	2,101		(845)	16
Treasury stock, beginning balance (in shares) at Jun. 30, 2024			0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of shares under equity awards, net of shares withheld for taxes and other	(35)		$ (25)	(10)
Net income attributable to GE HealthCare	470				470
Dividends declared	(14)				(14)
Other comprehensive income (loss) attributable to GE HealthCare	74						74
Changes in equity attributable to noncontrolling interests	2							2
Share-based compensation	$ 21			21
Equity, ending balance (in shares) at Sep. 30, 2024	457,144,443	457,000,000
Equity, ending balance at Sep. 30, 2024	$ 8,335	$ 5	$ (25)	$ 6,551	$ 2,558		$ (771)	$ 18
Treasury stock, ending balance (in shares) at Sep. 30, 2024	(291,053)		0